scispace - formally typeset
S

Stephen V. Faraone

Researcher at State University of New York Upstate Medical University

Publications -  1470
Citations -  155368

Stephen V. Faraone is an academic researcher from State University of New York Upstate Medical University. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Bipolar disorder. The author has an hindex of 188, co-authored 1427 publications receiving 140298 citations. Previous affiliations of Stephen V. Faraone include University of Bergen & National Institute for Health Research.

Papers
More filters
Journal ArticleDOI

Family history study of posttraumatic stress disorder with secondary psychotic symptoms.

TL;DR: PTSD with secondary psychotic symptoms was not associated with familial psychosis, suggesting it does not reflect the presence of an underlying psychotic disorder.
Journal ArticleDOI

Reexamining the Familial Association Between Asthma and ADHD in Girls

TL;DR: The results extend to female probands’ previously reported findings that asthma and ADHD are independently transmitted in families and support the conclusion that ADHD symptoms should not be dismissed as part of asthma symptomatology or a consequence of its treatment.
Journal ArticleDOI

Depression Treatment in Patients With Coronary Artery Disease: A Systematic Review

TL;DR: Antidepressant and/or psychotherapy, particularly as part of the Coronary Psychosocial Evaluation Studies intervention, may improve prognosis in persistent depression among post-acute coronary syndrome patients.
Journal ArticleDOI

Can manic switches be predicted in pediatric major depression? A systematic literature review

TL;DR: Together, these papers found that manic switches in pediatric depression can be predicted by several risk factors, including positive family history of mood disorders, emotional and behavioral dysregulation, subthreshold mania, and psychosis.
Journal ArticleDOI

Toward quality care in ADHD: defining the goals of treatment.

TL;DR: The therapeutic goals in treating ADHD should address optimal treatment outcomes that go beyond modest reductions of ADHD symptoms to include syndromatic, symptomatic, and functional remission.